A Prospective, Multi-center, Single-arm Study of the Stomach, Intestinal and Pylorus Sparing (SIPS) Procedure



Status:Completed
Conditions:Obesity Weight Loss
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:18 - 65
Updated:5/6/2017
Start Date:December 11, 2014
End Date:January 18, 2017

Use our guide to learn which trials are right for you!

This study is a prospective, multi-center, single-arm study evaluating the SIPS procedure.
Subjects who meet the eligibility criteria will be considered for study participation and
will be followed through 12 months.

SIPS is a single-anastomosis duodeno-intestinal switch procedure. Preliminary data from
Sanchez-Pernaute et al. (Surg Obes Relat Dis 2013;9:731) indicates that this procedure is
safe, quick to perform, and offers good results for treatment of both morbid obesity and its
metabolic comorbidities. CovidienTM plans to further investigate this procedure and has
proposed a prospective clinical study to obtain data on subject outcomes through 12 months
following the SIPS procedure.

Inclusion Criteria:

- The subject must be 18-65 years of age

- The subject must be willing and able to participate in the study procedures and to
understand and sign the informed consent

- The subject is under consideration for surgery for obesity or metabolic disease and
elects to undergo a primary SIPS procedure

- The subject has a BMI of 35-40 kg/m2 with at least 1 obesity-related comorbidity or a
BMI of 40-60 kg/m2

Exclusion Criteria:

- Any female subject who is pregnant, or is actively breast-feeding

- Any subject who is considered to be part of a vulnerable population (e.g. prisoners
or those with psychological concerns or those without sufficient mental capacity)

- The procedure is an emergency procedure

- The procedure is a revision/reoperation for the same indication

- The subject is unable or unwilling to comply with the study requirements or follow-up
schedule

- The subject has conditions which, in the opinion of the investigator, will not be
appropriate for the study (e.g. severe cardiovascular disease, history of
gastrointestinal (GI) malignancy, history of upper GI surgery, open cholecystectomy,
history of intestinal surgery, immunosuppression, or non-ambulatory)

- The subject has an estimated life expectancy of less than 6 months

- The subject has participated in an investigational drug or device research study
within 30 days of enrollment
We found this trial at
7
sites
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
400
Celebration, Florida 34747
?
mi
from
Celebration, FL
Click here to add this to my saved trials
?
mi
from
Cary, NC
Click here to add this to my saved trials
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
Parker, CO
Click here to add this to my saved trials